Unknown

Dataset Information

0

Novel Latency Reversal Agents for HIV-1 Cure.


ABSTRACT: Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART is not curative owing to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals. This review describes current pharmacologic approaches to reactivate the latent reservoir so that infected cells can be recognized and targeted, with the ultimate goal of achieving an HIV-1 cure.

SUBMITTER: Spivak AM 

PROVIDER: S-EPMC5892446 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Latency Reversal Agents for HIV-1 Cure.

Spivak Adam M AM   Planelles Vicente V  

Annual review of medicine 20171103


Antiretroviral therapy (ART) has rendered HIV-1 infection a treatable illness; however, ART is not curative owing to the persistence of replication-competent, latent proviruses in long-lived resting T cells. Strategies that target these latently infected cells and allow immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals. This review describes current pharmacologic approaches to reactivate the latent reservoir so that infected cells can  ...[more]

Similar Datasets

2022-02-06 | GSE196059 | GEO
| S-EPMC9177988 | biostudies-literature
2022-08-24 | GSE195855 | GEO
| S-EPMC7112239 | biostudies-literature
| S-EPMC6950696 | biostudies-literature
| S-EPMC7762775 | biostudies-literature
2016-09-17 | GSE82061 | GEO
| S-EPMC7601709 | biostudies-literature
| S-EPMC9318874 | biostudies-literature
| PRJNA803185 | ENA